Company Sas Pharma Plus Srl with Fiscal Code 28018091
recorded a turnover of 2024 of
285.016,
with a net profit of
8.088
and having an average number of employees of
3.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Sas Pharma Plus Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
242.248
218.136
194.571
224.269
240.977
301.987
289.699
297.262
317.841
285.016
Total Income - EUR
242.338
218.189
194.501
224.272
241.005
301.990
289.776
300.051
318.083
285.809
Total Expenses - EUR
210.591
193.908
179.122
202.132
219.103
262.283
257.389
273.320
291.986
276.054
Gross Profit/Loss - EUR
31.746
24.281
15.380
22.140
21.902
39.706
32.388
26.730
26.097
9.755
Net Profit/Loss - EUR
26.067
19.863
13.260
19.897
19.491
36.910
29.548
23.789
22.980
8.088
Employees
3
4
3
3
4
4
4
4
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -9.8%, from 317.841 euro in the year 2023, to 285.016 euro in 2024.
The Net Profit decreased by -14.763 euro, from 22.980 euro in 2023, to 8.088 in the last year.
Check the financial reports for the company - Sas Pharma Plus Srl
Financial Rating - SAS PHARMA PLUS SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Sas Pharma Plus Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Sas Pharma Plus Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Sas Pharma Plus Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Sas Pharma Plus Srl - CUI 28018091
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
419
6.229
4.168
7.062
4.175
6.413
4.098
2.028
1.011
0
Current Assets
94.520
66.008
60.742
70.682
80.967
115.581
126.563
88.673
91.882
60.711
Inventories
27.526
23.082
24.274
24.101
32.132
44.188
36.633
39.451
41.100
41.055
Receivables
12.999
4.643
13.875
19.841
14.790
12.817
14.858
32.295
32.028
14.629
Cash
53.996
38.282
22.592
26.740
34.044
58.576
75.071
16.927
18.754
5.027
Shareholders Funds
26.185
20.000
13.394
20.029
19.620
37.036
29.672
23.913
23.104
8.212
Social Capital
90
89
88
86
84
83
81
81
81
80
Debts
68.754
52.237
51.534
57.715
65.521
84.958
100.989
66.788
69.789
52.500
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
60.711 euro in 2024 which includes Inventories of
41.055 euro, Receivables of
14.629 euro and cash availability of
5.027 euro.
The company's Equity was valued at
8.212 euro, while total Liabilities amounted to
52.500 euro.
Equity decreased by -14.763 euro, from 23.104 euro in 2023, to 8.212 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Sas Pharma Plus Srl